Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Priority Technology Holdings, Inc.Priority Technology Holdings Reports 9.1% Revenue Growth to $239.8 Million in Q2 2025
National Vision Holdings, Inc.National Vision Holdings Reports 7.7% Revenue Growth to $486.4 Million in Q2 2025
OFG BANCORPOFG Bancorp Reports Q2 2025 Financial Results with Increased Net Income and Assets
WHITE MOUNTAINS INSURANCE GROUP LTDWhite Mountains Insurance Group Reports Revenue Surge to $689.2 Million and Net Income Recovery in Latest Quarter
IROBOT CORPiRobot Reports 23.3% Revenue Decline and $22.8 Million Net Loss in Q2 2025
Rallybio CorpRallybio Reports Q2 2025 Financial Results, Revenue Declines to $212,000
NOMAD POWER SOLUTIONS, INC.Lixte Biotechnology Reports Q2 2025 Financial Results with Reduced Net Loss
Wheels Up Experience Inc.Wheels Up Reports 3% Revenue Decline and $82.3 Million Net Loss in Q2 2025
PATRICK INDUSTRIES INCPatrick Industries Reports 3% Net Sales Increase to $1.05 Billion in Q2 2025
Leatt CorpLeatt Corporation Reports 61% Revenue Growth to $16.18 Million in Latest Quarter
UroGen Pharma Ltd.UroGen Pharma Reports 10.8% Revenue Growth but Incurred $49.9 Million Net Loss in Q2 2025
Senti Biosciences Holdings, Inc.Senti Biosciences Reports $14.7 Million Net Loss in Q2 2025, Seeks Additional Funding
Replimune Group, Inc.Replimune Reports $86.7 Million Net Loss and Increased Operating Expenses for Q2 2025
RAPT Therapeutics, Inc.RAPT Therapeutics Reports Improved Q2 2025 Net Loss of $17.6 Million
Barinthus Biotherapeutics plc.Barinthus Biotherapeutics Reports $21.1 Million Net Loss for Q2 2025, Focuses on Immunology Programs
Sabre CorpSabre Corporation Reports $256.5 Million Net Loss and $687.1 Million Revenue in Q2 2025
SILENCE THERAPEUTICS PLCSilence Therapeutics Reports Significant Revenue Decline and Increased R&D Expenses in Q2 2025
Burford Capital LtdBurford Capital Reports 20% Revenue Growth and 64% Increase in Net Income for Q2 2025
MARKETWISE, INC.MarketWise Reports 23.9% Revenue Decline and Decreased Profitability in Q2 2025
CUMULUS MEDIA INCCumulus Media Reports 9.2% Revenue Decline in Q2 2025, Improves Operating Income
BlackRock TCP Capital Corp.BlackRock TCP Capital Corp. Reports Q2 2025 Financial Results with Decrease in Net Investment Income
NCR VOYIX CorpNCR Voyix Reports $666 Million Revenue in Q2 2025, Net Income Improves to $1 Million
PepGen Inc.PepGen Inc. Reports $23.1 Million Net Loss in Q2 2025, Focuses on New Treatment Candidate
PMV Pharmaceuticals, Inc.PMV Pharmaceuticals Reports $21.2 Million Net Loss in Q2 2025, Increases R&D Spending
Star HoldingsStar Holdings Reports 37.7% Revenue Growth but $39.7 Million Net Loss in Q2 2025